Biocon, a leading player in the biopharmaceutical industry, has announced impressive financial results for Q1FY25, showcasing a remarkable 550% surge in net profit and a significant 30% increase in revenue.
Key Financial Highlights:
Biocon reported consolidated revenue of INR 4,567 crore for Q1FY25, marking a robust 30% increase from the same period last year. This revenue growth is a testament to…
Biocon, a leading biotechnology firm, announced a dramatic increase in its consolidated profit after tax for the first quarter ending June 2024. The company’s profit surged more than six times to ₹660 crore, driven by a significant one-time gain resulting from its collaboration with Eris Lifesciences through Biocon Biologics.
The substantial profit growth highlights the impact of strategic…
